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Hemolysis is a complication in septic infections with Staphy-
lococcus aureus, whichutilizes the releasedHbas an iron source.
S. aureus can acquire heme in vitro from hemoglobin (Hb) by a
heme-sequestering mechanism that involves proteins from
the S. aureus iron-regulated surface determinant (Isd) system.
However, the host has its own mechanism to recapture the free
Hb via haptoglobin (Hp) binding and uptake of Hb-Hp by the
CD163 receptor in macrophages. It has so far remained unclear
how the Isd system competes with this host iron recycling sys-
tem in situ to obtain the important nutrient. By binding and
uptake studies, we now show that the IsdHprotein, which serves
as an Hb receptor in the Isd system, directly interferes with the
CD163-mediated clearance by binding the Hb-Hp complex and
inhibiting CD163 recognition. Analysis of truncated IsdH vari-
ants including one or more of three near iron transporter
domains, IsdHN1, IsdHN2, and IsdHN3, revealed that Hb binding
of IsdHN1 and IsdHN2 accounted for the high affinity for Hb-Hp
complexes. The third near iron transporter domain, IsdHN3,
exhibited redox-dependent heme extraction, when Hb in the
Hb-Hp complex was in the oxidized met form but not in the
reduced oxy form. IsdB, the other S. aureus Hb receptor, failed
to extract heme from Hb-Hp, and it was a poor competitor for
Hb-Hp binding to CD163. This indicates thatHb recognition by
IsdH, but not by IsdB, sterically inhibits the receptor recogni-
tion of Hb-Hp. This function of IsdH may have an overall stim-
ulatory effect on S. aureus heme acquisition and growth.
Staphylococcus aureus is aGram-positive bacterium that col-
onizes approximately one-third of the human population (1). It
can be invasive and cause an array of diseases including hemol-
ysis and septic shock. Successful host invasion involves com-
promising the efficacy of the immune system and efficient
acquisition of essential nutrients including iron. Like a number
of other pathogenic bacteria (e.g. strains of Escherichia coli,
Pseudomonas, and Streptococci) (2–4), S. aureus secretes an
-hemolysin that integrates in red blood cell membranes and
induces osmotic hemolysis. Liberation of Hb into plasma facil-
itates S. aureus acquisition of iron by means of an iron-seques-
tering pathway designated the iron-regulated surface determi-
nant (Isd)3 system (5, 6). S. aureus expresses several different
Isd proteins (IsdA, IsdB, IsdC, IsdE, IsdF, IsdG, and IsdH) that
orchestrate the acquisition of hostHbheme iron. The functions
of most of these proteins have been elucidated: extraction of
heme is achieved by the two bacterial surface-exposed Hb-re-
ceptors, IsdB and IsdH; transport of heme across the bacterial
cell wall and plasma membrane is performed by IsdA and IsdC
together with the membrane protein IsdEF complex; and the
heme oxygenase enzymes IsdG and IsdH, located in the cyto-
plasm, finally cleave the porphyrin ring (reviewed in Ref. 7).
Although the role of Isd proteins in the sequestering of iron
from free Hb is well understood, this may not apply to the sit-
uation in the blood where extracellular Hb is found in complex
with Hp.
The heme-binding function of S. aureus Isd proteins—IsdA,
IsdB, IsdC, and IsdH—is conferred by the presence of a near
iron transporter (NEAT) domain with a conserved heme-bind-
ing pocket (8). Importantly, the heme-binding domain alone is
unable to extract heme from Hb, and IsdB and IsdH contain
additional NEAT domains to achieve this function (9). Thus,
IsdH contains three NEAT domains of which the first and sec-
ond NEAT domain (IsdHN1 and IsdHN2) bind to Hb but lack
heme binding activity, whereas the third, C-terminal, NEAT
domain (IsdHN3) carries the single heme-binding site of IsdH.
IsdHN2 and IsdHN3 are connected by an -helical linker
domain and the IsdHN2-linker-IsdHN3 region is the minimal
fragment of the IsdH receptor that retains native ability to cap-
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(IsdBN1 and IsdBN2) structure connected with an -helical
linker domain, similar to the minimal functional fragment of
IsdH (8). In addition to Hb binding, the IsdHN1 domain is also
reported to bind other ligands including Hp (12, 13). Indepen-
dent of heme extraction, IsdH also plays a role in S. aureus
immune evasion by promoting degradation of bound comple-
ment C3, thereby avoiding opsonophagocytosis (14).
Hb released into human plasma during hemolysis binds rap-
idly to plasma Hp, which protects against the highly oxidative
and toxic properties of Hb by direct shielding of oxidative spots
(15, 16) and by the promotion of Hb-uptake via the macro-
phage-specific endocytic receptor CD163 (17–21). Hp exists in
three main variants designated Hp1-1, Hp2–1, and Hp2-2,
where Hp1-1 is a Hp dimer, whereas the two other variants are
found as different multimeric forms. All forms bind -Hb
dimers in the Hp region distal to the center of the Hp protein.
Structural data have shown that IsdH binds to Hb in Hb-Hp
complexes close to the site for interaction of Hp and CD163
(22).
In the present study,we show that IsdHonly bindsHb-Hp via
a direct Hb interaction without direct contact to the Hp sub-
unit, in contrast to previous reporting (12, 13, 23) of a direct low
affinity interaction between IsdH and Hp. Furthermore, this
study describes how the interaction with Hb-Hp leads to heme
extraction and obstruction of CD163-mediated clearance of
Hb-Hp complexes in macrophages.
Results
Binding of IsdH to Hb-Hp Complexes—IsdH truncation vari-
ants IsdHN1, IsdHN2N3, IsdHN1N2N3, and IsdBN1N2 with a His6
tag were expressed recombinantly and analyzed by SDS-PAGE
(Fig. 1). Binding of the IsdH variants to Hb-Hp complexes was
evaluated by SPR analysis (Fig. 2, A and B). The apparent equi-
librium dissociation constants for binding of IsdHN1 (one Hb
binding site), IsdHN2N3 (one Hb binding site), or IsdHN1N2N3
(two Hb binding sites) to Hb-Hp1-1 or Hp2-2 were 70,
120, and30 nM, respectively (Fig. 2). The binding curves of
IsdHN1 and IsdHN1N2N3 were different in the sense that IsdHN1
and IsdHN2N3 displayed faster off rates, compared with
IsdHN1N2N3. These results suggest that the two Hb-binding
domains in IsdHN1 and IsdHN2, together increase the overall
functional affinity of IsdHn1N2N3 for Hb-Hp. No significant
binding of any of the IsdH constructs was seen to Hp1-1 and
Hp2-2 (Fig. 2, C and D).
To further characterize the interaction between IsdHN1 and
Hb or Hb-Hp complexes in solution, we employed size exclu-
sion chromatography (SEC) with in-line right angle light scat-
tering (RALS). The molecular mass of IsdHN1 determined by
SEC-RALS in solution (18.6 kDa) was close to the monomer
molecular mass based on sequence and determined by mass
spectrometry (18,907 Da) (Fig. 3). Themajor component of the
Hp1-1 preparation was a93-kDa species, consistent with the
presence of the Hp1-1 dimer, including 20% mass contribu-
tion because of glycosylation; a minor peak at the exclusion
volume of the SEC columnwas assumed to be an aggregate. Hb
eluted as a single asymmetric peak, indicative of the well char-
acterized dimer-tetramer equilibrium (24); the measured
molecular mass of 57 kDa suggested that the protein was pre-
dominantly in the tetrameric state under the experimental con-
ditions. Analysis of a 1:1 (by mass) mixture of IsdHN1 with Hp
showed no significant change in the peak elution times or
molecularmasses as determined byRALS (Fig. 3); thus no inter-
action between IsdHN1 and Hp could be detected. In contrast,
FIGURE 1. SDS-PAGE of IsdH constructs. A, IsdHN1, IsdHN2N3, IsdHN1N2N3, and IsdBN1N2 were expressed recombinantly in E. coli with N-terminal His6 tags,
purified, and analyzed by SDS-PAGE. B, a schematic overview of full-length IsdH, IsdB, and the derived constructs used in this study. Full-length IsdH consists
of three NEAT domains and a linker connecting the second and third NEAT domain. Full-length IsdB consists of twoNEAT domains connectedwith a linker. An
LPXTG sequence in C-terminal part links IsdH and IsdB to the bacterial cell wall (40). The truncated variants IsdHN1N2N3 (residues 82–655), IsdHN2N3 (residues
321–655), IsdHN1 (residues 86–229), and IsdBN1N2 (residues 120–459) were used in this study.
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Hp and Hb in an 1:1 (by mass) mixture formed a complex with
amolecularmass of 152 kDa, consistent with a stoichiometry of
one Hp1-1 dimer bound to two Hb -dimers; the absence of
any detectable free Hb is consistent with the known high affin-
ity binding between Hp and Hb. The elution of this complex
shifted to an earlier time point, and the molecular mass of the
complex increased upon addition of IsdHN1 (Fig. 3), indicating
formation of a ternary Hb-Hp-IsdHN1 complex. Taken
together, the SPR and SEC-RALS data show that Hb is neces-
sary for interaction between Hb-Hp and IsdH, most likely via a
direct interaction between IsdH and Hb.
IsdH Acquisition of Heme from Hb-Hp—To determine
whether IsdHN3 is capable of extracting heme from Hb-Hp,
heme transfer from Hb-Hp to IsdHN2N3 was monitored using
UV-visible spectroscopy, taking advantage of the different
spectra generated when heme is bound to the globin or bound
to the IsdH protein. Previous studies have confirmed rapid
heme transfer to IsdHN2N3 from metHb (9, 13). Similar results
were obtained when metHb was incubated in the presence of
added IsdHN2N3 (Fig. 4A). Significant absorbance changes were
also evident whenmetHb-Hp1-1 was incubated with IsdHN2N3
(Fig. 4C), indicating that IsdH is capable of extracting heme
from Hb in complex with Hp. When IsdHN2N3 was mixed with
ferrous oxyHb or oxyHb-Hp1-1, no spectral changes were
detected (Fig. 4, E and F). Thus, ferrous oxyHb has to be oxi-
dized to metHb for IsdH to be able to extract heme.
IsdH Interference with CD163 Binding of Hb-Hp—Surface
plasmon resonance (SPR) analysis was used to determine
whether the high affinity binding of IsdH to Hb-Hp interferes
with the binding of the complex to purified CD163. A robust
SPR response was obtained when Hb-Hp1-1 was injected over
CD163 immobilized on the SPR chip surface (Fig. 5A, Buffer),
indicating a complex forming between Hb-Hp1-1 and CD163.
In contrast, when Hb-Hp1-1 was injected together with an
equimolar concentration of IsdHN1, the SPR response was
strongly attenuated (Fig. 5A), suggesting that IsdHN1 interferes
with the interaction of Hb-Hp1-1 with CD163. Similarly, the
IsdHN2N3 and IsdHN1N2N3 proteins also blocked the Hb-Hp1-1
interactions with CD163 (Fig. 5, A and C). Similar results were
obtained for interactions of Hb-Hp2-2 with CD163 (Fig. 5, B
and D). All IsdH constructs exhibited dose-dependent inhibi-
tion of Hb-Hp binding to CD163 with IsdHN1N2N3 showing the
highest potency. The IsdH variants were slightlymore potent in
FIGURE2.SPRanalysis of IsdHbinding toHb-Hp.A andB, bindingof 100nM
IsdHN1, IsdHN2N3, and IsdHN1N2N3 to immobilized Hp1-1 saturated with Hb (A)
or immobilizedHp2-2 saturatedwithHb (B). Onbasis of thesedata, the appar-
ent KD values were estimated by fitting the plateau binding response: IsdH
N1
binding toHb-Hp1-1 KD 74 18 nM and binding toHb-Hp2-2 KD 71 19
nM; IsdHN2N3 binding toHb-Hp1-1KD11717nMandbinding toHb-Hp2-2
KD 127 18 nM; IsdH
N1N2N3 binding to Hb-Hp1-1 KD 28 10 nM and to
Hb-Hp2-2 KD 33 9 nM. The values are represented asmeans S.D., and r
2
of the fitswere all above0.98.C andD, bindingof 100nM IsdHN1, IsdHN2N3, and
IsdHN1N2N3 to immobilized Hp1-1 (C) or immobilized Hp2-2 (D). The binding
was investigated on two independently produced flow cells for both Hp1-1
andHp2-2, respectively. All experimentswere at least repeated in triplicate to
each flow cell. The apparent binding constants are determined based on a
triplicate binding experiment to a single flow cell with either Hp1-1 or Hp2-2.
FIGURE 3. SEC-LS analysis of IsdHN1 mixtures with Hp or Hb-Hp. Elution
profiles are shown from50-l injections of IsdHN1, Hp1-1, or Hb at 1mg/ml or
mixtures of IsdHN1Hp1-1 (1mg/ml each), Hp1-1Hb (1mg/ml each), and
IsdHN1 Hp1-1 Hb (0.4, 1, and 1 mg/ml respectively). Refractometer volt-
age (solid line) is proportional to mass concentration. Molecular mass was
calculated frommultiple refractive index and light scattering measurements
across eachpeak (solid data points), and themolecularmass calculated across
the whole peak is shown.
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their inhibition of Hb-Hp2-2 (Fig. 5, B and D) binding com-
pared with Hb-Hp1-1 (Fig. 5, A and C).
To investigate how these interactions may impact on clear-
ance of Hb-Hp complexes by cellular CD163, we analyzed the
endocytosis of fluorophore-labeled Hb-Hp2-2 by transfected
CD163-expressing CHO cells (CHO CD163) in the presence
of IsdHN1N2N3, IsdHN2N3, or IsdHN1. As expected, confocal
microscopy showed that fluorophore-labeled Hb-Hp (Fig. 6A,
green) only was endocytosed when CHO cells were expressing
CD163 (Fig. 6A, red). A substantial inhibition of CD163-medi-
ated vesicular Hb-Hp uptake was observed in the presence of
IsdHN1N2N3, IsdHN2N3, or IsdHN1 compared with the positive
control (Fig. 6A). The inhibitory effect by IsdH was quantified
by analyzing the cellular uptake of fluorescent Hb-Hp2-2 by
flow cytometry (Fig. 6B). All IsdH constructs inhibited Hb-Hp
uptake in a dose-dependent manner, with IsdHN1N2N3 being
most efficient showing a 6-fold reduction in uptake using an
equimolar concentration of the Hb-Hp units. Complete inhibi-
tion, corresponding to the background level in the mock trans-
fectedCHOcells, was seen at 5molar excess of IsdHN1N2N3 and
IsdHN1. The inhibitory effect by IsdH was also evident in flow
cytometric analysis of monocytes/macrophages, the cell type
responsible for the in vivo clearance of Hb-Hp (Fig. 7). The flow
cytometric analysis shows that an equimolar concentration of
IsdHN1N2N3 reduced themean fluorescence intensity (MFI) sig-
nal of Hb-Hp 4-fold. Similar inhibition was a seen with
IsdHN1 and IsdHN2N3, although 5-fold higher concentrations of
these IsdH truncationmutants were needed to obtain the same
level of inhibition.
Comparative Analyses of IsdB—Next, because IsdH and IsdB
share a high degree of structural homology and both are
reported to function as Hb receptors, interactions of IsdB with
the Hb-Hp complex and its removal by CD163 were investi-
gated. IsdBN1N2was analyzed byUV-visible spectroscopy for its
ability to transfer heme (Fig. 8, A and B). Although IsdBN1N2
rapidly transfers heme from metHb, we could not detect any
heme transfer from metHb-Hp. In contrast to IsdH, SPR anal-
ysis showed no or very weak inhibition of Hb-Hp binding to
FIGURE 4. IsdH-mediated heme transfer fromHb andHb-Hp. A–F, spectral changes over time for 1.5MmetHb (tetramer)mixedwith 13M IsdHN2N3 (A) or
13M IsdHN1 (which cannot extract heme) (B), 1.5MmetHb-Hp1-1 (Hpdimer; twoHbdimers)mixedwith 13M IsdHN2N3 (C) or 13M IsdHN1 (D), 1.5MoxyHb
(tetramer) mixed with 13M IsdHN2N3 (E), and 1.5M oxyHb-Hp1-1 (Hp dimer; two Hb dimers) mixed with 13M IsdHN2N3 (F). The time points 0, 60, and 300 s
indicate timeafter the first recording. For comparison, 1.5MmetHbor 1.5MmetHb-Hp1-1mixed1:1with PBS are included (solid line). By estimating from the
absorbance changes only, 39.6 0.2% and 12.8 1.7% (n 3) of heme was transferred to IsdHN2N3 in 300 s frommetHb andmetHb-Hp1-1, respectively. No
measurable transfer to IsdHN1 was seen in this time span.
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CD163 by IsdBN1N2 (Fig. 8C), although IsdBN1N2 was able to
bind to Hb-Hp (Fig. 8D). Finally, IsdBN1N2 did not inhibit
uptake of fluorophore-labeled Hb-Hp2-2 in CHO CD163
(Fig. 8E).
Discussion
This study shows that S. aureus IsdH blocks the CD163-me-
diated uptake of Hb-Hp complexes, which instantly formwhen
Hb is released during intravascular hemolysis. The blockage is
biologically meaningful because it inhibits the normal mecha-
nism for Hb degradation in the host and therefore secures a
pool of Hb-iron for the pathogen.
The present heme transfer kinetic studies shows that IsdH is
able to extract heme frommetHb-Hp but not from oxyHb-Hp.
This is in line with previous studies on freeHb showing that the
third NEAT domain, IsdHN3, binds ferric heme tighter than
ferrous heme (25) and studies with the other S. aureus receptor,
IsdB, which does not extract heme fromoxyHb (26). It is tempt-
ing to speculate that the IsdH blocking of the CD163-mediated
pathway for Hb-Hp uptake may benefit S. aureus by providing
time for the spontaneous oxidation of Hb from its ferrous form
to ferric metHb, from which IsdH then can extract the heme.
Our data indicate that both the IsdHN1 and IsdHN2 domains
contribute to the binding of the Hb-Hp complexes. This is in
line with previous data showing that IsdHN1 only binds the Hb
-subunit, whereas IsdHN2 binds either the Hb - or the Hb
-subunit (27). Given that Hb-Hp complexes contain Hb 
dimers, the higher affinity of IsdHN1N2N3 suggests that IsdHN1
and IsdHN2 are bound simultaneously to the Hb - and -sub-
units, thereby stabilizing the interaction. By presenting the
knownHb-Hp-IsdHN1 crystal structure in a view together with
amodel of twoCD163 scavenger receptor cysteine-rich (SRCR)
domains, previously shown to bind Hp in the Hb-Hp complex,
Fig. 9 illustrates how IsdHN1 blocks the CD163 binding site on
Hb-Hp (28, 29). Fig. 9 also illustrates how two positively
charged amino acids, Lys317 and Arg307, in Hp interact with
acidic calcium-coordinating residues in CD163. The structural
model suggests that this interaction (28) will be obstructed
when IsdH binds to adjacent Hb subunit. However, x-ray crys-
tal structures are needed to confirm the domain interactions of
IsdHN1N2N3 with Hp-bound Hb.
IsdHN1 has, in contrast to our findings, been reported to bind
Hp with a KD in the micromolar (12) or nanomolar range (13).
FIGURE 5. SPR analysis of CD163-mediated binding of Hb-Hp in presence
of IsdH. A and B, sensorgrams displaying binding of Hb-Hp1-1 (A) and
Hb-Hp2-2 (B) to immobilized CD163 in presence of 1.5 molar equivalent of
IsdHN1, IsdHN2N3, and IsdHN1N2N3 or runningbuffer as control.C andD, relative
plateau response of immobilized CD163 binding of Hb-Hp1-1 (C) and
Hb-Hp2-2 (D) are plotted against the indicated molar ratio of IsdHN1 (E),
IsdHN2N3 (), or IsdHN1N2N3(F). Reproduction of the SPR experiments was
ensured by preparing two individual chips with two individual flow cells with
either Hp1-1 or Hp2-2. On both chips triplicate repeats of triplicate runs of
each samplewasperformed. The showndata are representative sensorgrams
(A and B) and representative results from triplicate experiments to a single
flow cell (C and D).
FIGURE 6. Analysis of cellular uptake of Hb-Hp2-2 by CD163-expressing
cells.A, confocalmicroscopy images of endocytoticHb-HpuptakebyCD163-
expressing cells. CHO CD163 cells were incubated with 46 g/ml Atto-488-
labeled Hb-Hp2-2 and IsdHN1, IsdHN2N3, or IsdHN1N2N3 in 5-fold molar excess
over Hb-Hp. Atto-488-labeled Hb-Hp2-2 is shown in green, DAPI staining of
nuclei is shown in blue, and CD163 surface immunostaining (Alexa 647) is
shown in red. Mock transfected CHO cells (right) were included as a negative
control. B, dose-response inhibition of endocytotic uptake of Atto-488
labeledHb-Hp2-2byCHOCD163cells inpresencesof increasingmolar excess
of IsdHN1 (E), IsdHN2N3 (f), or IsdHN1N2N3 (Œ). Fluorescence signals were
detected by flow cytometry and displayed as MFI. Background uptake in
mock transfected CHO cells is indicated with a dashed line. The data are rep-
resented as means  S.D. (n  3) from one representative experiment of
three.
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In our study, we could not detect Hp binding by any of the IsdH
constructs using either the sensitive SPR analyses or SEC-RALS
in line with size exclusion chromatography. Furthermore, a
recently published structure of IsdHN1 binding to Hb-Hp
shows that IsdHN1molecules only bound toHb-subunits (22)
with no contact toHp. Given thatHb-Hp is one of the strongest
known non-covalent interactions (30), it is possible that trace
contamination of Hp preparations with Hb gave rise to false
positive interactions with IsdH observed in previous studies.
IsdH shares a high degree of homologywith IsdB (11) and can
extract heme frommetHb (26).However, our data revealed that
IsdB cannot extract heme frommetHb-Hp, and neither is IsdB
a strong inhibitor of the Hb-Hp-CD163 interaction. This
clearly differentiates the role of IsdH and IsdB. Because Hb is
complexed instantly with Hp in the human circulation as long
as Hp exceeds the Hb concentration in plasma, the ability to
sequester this pool of iron through the IsdH receptor may have
provided a selective advantage during S. aureus evolution,
explaining the presence of two different Hb receptors in this
organism.
From a clinical point of view, IsdH blocking ofHb-Hp uptake
byCD163mayworsen hemolytic sepsis by stimulating bacterial
growth. Furthermore, it may enhance the inflammatory
response, not only because the iron supplementation stimu-
lates bacterial growth but also because of inhibition of Hb
uptake in plasma, which is a prerequisite for conversion of
heme to anti-inflammatory heme metabolites (CO and biliru-
bin) (31). The inhibitory effects of the S. aureus heme extrac-
tion system on the CD163-mediated Hb removal may also
affect the validity of plasma Hp as a biomarker of hemolysis
during S. aureus sepsis, because the well known negative corre-
lation between Hp and hemolysis relies on Hb-Hp scavenging
(32). Direct inhibition by IsdH and thereby inefficient Hp scav-
engingmay skew this correlation and underestimate hemolysis.
Finally, it is tempting to speculate that other hemolytic bacteria
that extract heme from Hb might also have mechanisms to
block clearance of Hb-Hp complexes.
Experimental Procedures
Protein Production—The DNA sequence encoding IsdHN1
(residues 86–229) with an added N-terminal His6 tag and a
thrombin cleavage site was cloned into the NdeI and BamHI
sites (Genscript) of the pET-22b() (Novagen) vector as previ-
ously described (22). The sequence encoding IsdHN2N3 (resi-
dues 321–655) was cloned in theXhoI and BamHI sites of pET-
15b (Novagen) in line with the vector encoded His6 tag and
purified over nickel affinity, anion exchange chromatography
as previously described (10). IsdHN1N2N3 (residues 82–655)
and IsdBN1N2 (residues 120–459) were expressed and purified
according to the same method as used for IsdHN2N3 puri-
fication. The protein purity was assessed by SDS gel
electrophoresis
Cell Culture—Human CD163-expressing Chinese hamster
ovary cells (CHO CD163) were generated and cultured as pre-
viously described (33). Human mononuclear leukocytes were
purified from blood from healthy volunteers by Ficoll-Paque
centrifugation and seeded in 24-well plates (Nunc, Roskilde,
Denmark) at a density of 5  105 monocytes/well. Monocytes
were isolated by plastic adherence, as described (34) washing
away non-adherent cells after 3 h of incubation at 37 °C and 5%
CO2 in RPMI. Themonocytes were cultured for 3 days in RPMI
supplemented with 2%AB serum (Biowest, Nuaille´, France), 20
FIGURE 7. Flow cytometric analysis of uptake of Hb-Hp2-2 by dexameth-
asone-treated monocytes. A, adherent 3-day-old monocytes treated with
2.5  107 M dexamethasone were incubated with 23 g/ml Atto-488-la-
beled Hb-Hp2-2 and IsdHN1, IsdHN2N3, or IsdHN1N2N3 in 1-, 5-, and 20-fold
molar excess over Hb-Hp. B, a polyclonal rabbit anti-human CD163 IgG (50
g/ml) and an irrelevant polyclonal rabbit anti-human antibody (50 g/ml)
were used as positive and negative inhibition controls respectively. The data
from one representative experiment of three are shown.
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ng/ml M-CSF (Gibco, Life Technologies), and 2.5  107 M
dexamethasone (Sigma-Aldrich) to increase CD163 expression
as previously reported (34).
Fluorophore Labeling of Hp—HumanHp2-2 (Sigma-Aldrich)
was fluorescently labeled as described previously (35). Briefly,
Hp2-2 was labeled with Atto-488 succinimidyl ester (Sigma-
Aldrich) by adding 65 g of dye/mg of protein to yield a degree
of labeling of 3 as confirmed by spectroscopy.
Confocal Microscopy—Confocal imaging was done as
described earlier (36). Briefly, CHOCD163 ormock transfected
CHO cells were seeded 3  104 cells/well on poly-D-lysine-
coated 8-well chambered coverslips (Nunc) and cultured in
serum-free CHO medium (CCM5; HyClone, Logan, UT) until
the next day. Hb-Hp complexes were formed by incubating
equimolar amounts of ferrous stabilizedHbA0 (Sigma-Aldrich)
with Atto-488-labeled Hp2-2 for 1 h. The cells were incubated
for 1 h with labeled Hb-Hp2-2 (46 g/ml) in the presence of
5-fold molar excess of IsdHN1, IsdHN2N3, or IsdHN1N2N3 (a 1:1
stoichiometry of IsdH binding to a Hb-Hp monomer unit was
assumed). The cells were washed in PBS and fixed in 4% form-
aldehyde for 10 min at room temperature. Immunostaining of
CD163 was performed by incubating the cells with 10 g/ml
rabbit anti-human CD163 IgG (Dako, Glostrup, Denmark) in
1% BSA in PBS for 45 min, followed by washing and 45 min of
incubationwith donkey anti-rabbit-conjugatedAlexa Fluor 647
(Molecular Probes, Eugene, OR) in 1% BSA in PBS. The nuclei
were stained with 300 ng/ml DAPI (Molecular Probes). The
cells were visualized using an Olympus FV10i confocal micro-
scope (Olympus Denmark A/S, Ballerup, Denmark) with a 60
NA 1.2 phase contrast water immersion objective.
Flow Cytometry—CHO cells were seeded in 24-well plates at
a density of 2 105 cells/well. The following day the cells were
FIGURE 8. IsdB heme transfer kinetics, SPR analysis, and cellular uptake of Hb-Hp2-2. A and B, spectral changes over time after mixing of 13M sIsdBN1N2
with 1.5MmetHb (tetramer) (A) or 1.5MmetHb-Hp1-1 (Hp dimer; twoHb dimers) (B). For comparison, 1.5MmetHb or 1.5MmetHb-Hp1-1mixed 1:1with
PBSare included. Byestimating fromtheabsorbance changes, 30.20.5% (n3)of hemewas transferred frommetHb to IsdB in300 s,whereasnomeasurable
transfer tometHb-Hp1-1was seen.C, relative plateau responseof immobilizedCD163bindingofHb-Hp1-1 (E) and (F) Hb-Hp2-2plotted against the indicated
molar ratios of IsdBN1N2.D, sensorgrams of 100 nM Hb-Hp1-1, Hb-Hp2-2, Hb, Hp1-1, or Hp2-2 binding to immobilized IsdBN1N2. E, confocal microscopy images
of endocytosis of Hb-Hp by CD163-expressing cells. CHO CD163 cells were incubated with 46 g/ml Atto-488-labeled Hb-Hp2-2 and IsdBN1N2 in 5-fold molar
excess over Hb-Hp. Atto-488-labeled Hb-Hp2-2 is shown in green, DAPI staining of nuclei is shown in blue, and CD163 surface immunostaining (Alexa 647) is
shown in red. Mock transfected CHO cells (right panel) were included as a negative control.
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incubated with Atto-488-labeled Hb-Hp2-2 (23 g/ml) mixed
with increasing ratios of IsdHN1, IsdHN2N3, or IsdHN1N2N3 in
CCM5 medium for 1 h at 37 °C 5% CO2. The cells were
detached by trypsination and washed twice in PBS 1% BSA.
Similar experiments were performed on 72-h cultured mono-
cytes with modifications. Briefly, uptake was performed in
RPMI 1% BSA, and monocytes were detached using macro-
phage detachment solution (Promocell, Heidelberg, Germany)
according to the manufacturer’s instructions. Polyclonal rabbit
anti-human CD163 IgG (Dako), earlier shown to specifically
inhibit Hb-Hp uptake by CD163 (37), and irrelevant polyclonal
rabbit anti-human IgG (Dako) were included as inhibition con-
trols, both at a concentration of 50 g/ml. Cellular uptake of
fluorescent Hb-Hp2-2 and CD163 expression was analyzed by
flow cytometry using a LSR II flow cytometer and FACSDiva
software (BD Biosciences, San Jose, CA) using the 488- and
633-nm lasers. Geometric MFI of a population of 10,000 cells
was calculated with FlowLogic software (Inivai Technologies)
and used to quantify Hb-Hp uptake.
Surface Plasmon Resonance—CD163 binding to Hb-Hp with
or without IsdH and IsdBN1N2 was studied by SPR on a Biacore
3000 instrument (Biacore, Uppsala, Sweden) with immobilized
CD163 on a CM5 chip as previously described (29). Hb-Hp2-2
and Hb-Hp1-1 complexes were formed as described above
using unlabeled Hb and diluted to 12.5g/ml in running buffer
(10 mMHEPES, 150mMNaCl, 2 mMCaCl2, and 0.005% Surfac-
tant P-20, pH 7.4). The Hb-Hp complexes were mixed with
increasing ratios of IsdHN1, IsdHN2N3, IsdHN1N2N3, or
IsdBN1N2. Each sample (40l) was injected with a flow rate of 5
l/min.
To confirm the affinity of IsdBN1N2 for Hb, Hb-Hp1-1, and
Hb-Hp2-2, IsdBN1N2was immobilized on aCM5 chip by inject-
ing 10 g/ml IsdBN1N2 in 10 mM sodium acetate, pH 4.0, to a
surface density of 0.075 pmol/mm2 and capping with 1 M
ethanolamine, pH 8.5. Samples (40 l) of Hb, Hp, or Hb-Hp
complexes in running buffer were injected over the chip at a
flow rate of 5 l/min in concentrations ranging from 50 to
500 nM.
For the affinity measurements of IsdH, Hp1-1 and Hp2-2
were immobilized on a CM5 chip in different flow cells in a 10
mM sodium acetate pH 4.0 buffer. Hb-Hp complexes were
formed by injecting 40 l of 100 g/ml Hb in running buffer
over the chip in each cycle followed by injection of 40 l of 25,
50, 100, 200, 300, 400, or 500 nM IsdHN1, IsdHN2N3, or
IsdHN1N2N3 at a flow rate of 5 l/min. Regeneration was
obtained by injecting two cycles of 10 l of regeneration buffer
(10 mM glycin, 20 mM EDTA, 500 mM NaCl, and 0.005% Sur-
factant P-20, pH 3.0). In parallel, endoglycosidase H, expressed
with a His6 tag, was used as a negative control to exclude the
possibility of the His tag binding to Hb-Hp or Hp. The data
were analyzed using BIAevaluation software 4.0.1, and the
apparent dissociation constants were obtained by fitting the
binding response of IsdH constructs to Hb-Hp1-1 and
Hb-Hp2-2 flow cells just prior to the end of injection (RPl) to the
previously described expression (38).
1
RPl

1
RMax

Kd
RMaxIsdH	
(Eq. 1)
Heme Transfer Kinetics—The transfer rate of heme from free
Hb and from Hp1-1-bound Hb to IsdH was measured using a
Cary 60 (Agilent Technologies, Glostrup, Denmark) UV-visible
spectrophotometer at 20 °C. Pure ferrous adult human HbA0
(Sigma-Aldrich) in the oxygenated form (oxyHb) was oxidized
to the ferric (met) form (metHb) by ferricyanide, as described
(39). Briefly, the lyophilizedHbwas dissolved inmilliQwater at
a concentration of 4–6 mM heme and incubated in the dark at
room temperature for 1 h with a 1.2 molar excess of potassium
ferricyanide K3Fe(CN)6 over heme. MetHb was desalted on a
PD-10 column (GE Healthcare) equilibrated with 100 mM
HEPES, pH 7.5, to remove ferricyanide and dialyzed against
milliQ water before use.
Concentrations ofmetHb and oxyHbwere determined using
extinction coefficients 179 mM1 cm1 at 405 nm and 14.6
mM1 cm1 at 577 nm, respectively (39). Hb-Hp complexes
weremade bymixing 1.5M (tetrameric)metHb or oxyHbwith
a 1.5 molar excess of Hp1-1 (Sigma-Aldrich) in PBS (pH 7.4),
assuming that one Hp1-1 dimer binds two Hb dimers.
IsdHN2N3, IsdHN1, or IsdBN1N2 (all 13 M in PBS) was mixed in
a 1-cmquartz cuvette 1:1 with eithermetHb or oxyHb (both 1.5
FIGURE 9. Model of S. aureus protein IsdH competing for CD163-mediated Hb-Hp uptake. During intravascular hemolysis, the macrophage-specific
receptor CD163 normally takes up complexes of Hb-Hp. Uptake and subsequent degradation of heme produces an anti-inflammatory response. The S. aureus
protein IsdHbinds toHb-Hpnear thebinding site of CD163,whichhinders the uptake ofHb-Hp. Bindingof IsdHN1 to the-subunit of Hb in theHb-Hp complex
sterically hinders binding of Hb-Hp to CD163. The Hb-Hp-IsdHN1 structure is from Stødkilde et al. (22) (Protein Data Bank code 4WJG), whereas the two SRCR
domains from CD163 were modeled from the structure of the SRCR domain of the scavenger receptor A-I (41) (Protein Data Bank code 2OY3). The positively
charged residues Arg307 and Lys317 from Hp (blue) interact with negatively charged, calcium-coordinated amino acids in SRCR 2 and 3 in CD163. The calcium
atoms are colored red.
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M in PBS) alone or bound to Hp1-1. Absorbance spectra were
recorded every 5 s in the range 350–450 nm for 300 s.
Size Exclusion Chromatography with In-line Right Angle
Light Scattering—SEC was performed on a Viscotek P2500 col-
umn (Malvern, Worcestershire, UK). RALS and refractive
index were measured on a Viscotek 305 Triple Detector Array
instrument (Malvern). The detectors and column were main-
tained at 30 °C. The light scattering cell was illuminated by a
laser diode (670 nm), and light scattered at an angle of 90° was
measured by a photodiode detector. The refractive index detec-
tor was a dual cell design. Calibration of the detectors and cal-
culation of sample weight-average molecular mass was per-
formed using theOmnisec software (Malvern). The instrument
was calibrated using multiple protein and polyethylene oxide
standards. Sample molecular mass was calculated using a spe-
cific refractive index increment with respect to sample concen-
tration (dn/dc) of 0.185 g/ml, neglecting possible deviations
because of the presence of co-factors or glycosylation.
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